INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Atika Capital Management LLC's Holding History (CIK: 0001599731)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 73,000 Value ($000) $6,097 Avg Close — Range —
Q3 2024
Shares 83,000 Value ($000) $6,073 Avg Close — Range —
Q2 2024
Shares 97,500 Value ($000) $6,678 Avg Close — Range —
Q1 2024
Shares 105,000 Value ($000) $7,266 Avg Close — Range —
Q4 2023
Shares 100,000 Value ($000) $7,162 Avg Close — Range —
Q3 2023
Shares 85,900 Value ($000) $4,475 Avg Close — Range —
Q2 2023
Shares 92,900 Value ($000) $5,882 Avg Close — Range —
Q1 2023
Shares 53,000 Value ($000) $2,870 Avg Close — Range —
Q4 2022
Shares 119,000 Value ($000) $6,297 Avg Close — Range —
Q3 2022
Shares 163,900 Value ($000) $7,627 Avg Close — Range —
Q2 2022
Shares 249,000 Value ($000) $14,213 Avg Close — Range —
Q1 2022
Shares 210,000 Value ($000) $12,850 Avg Close — Range —